Extracellular vesicles (EVs) secreted by tumors, which carry immunosuppressive molecules (such as PD-L1 and TGF-β), are also important mediators of tumor immune escape and possible targets for immunotherapy. The gene discussed is TGFB1; the disease is neoplasm.